NIH-funded research R01 grant

Investigating how GPR75 affects obesity-related heart and metabolic issues

Official title: GPR75 in obesity-driven cardiovascular and metabolic complications

Funded at New York Medical College · NIH-11037960 · Data updated 2026-11-12

This study is looking at how a specific protein called GPR75 affects health problems related to obesity, like heart disease and metabolic syndrome, to find new ways to help people with these conditions feel better.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionNew York Medical College
NIH-funded
Lab location1 site (Valhalla, United States)
Project startApril 1, 2023
Project endFebruary 28, 2027
Funding year2025
Award (this year)$510,454
NIH project number5R01HL168056-03
Project IDNIH-11037960 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals suffering from obesity-related metabolic and cardiovascular issues, such as hypertension or diabetes.

Less likely to help

Patients who are not affected by obesity or its related complications may not benefit from this research.

What this research studies

This research focuses on understanding the role of the G-protein coupled receptor 75 (GPR75) in the complications arising from obesity, such as metabolic syndrome and cardiovascular diseases. The team aims to identify how GPR75 interacts with certain lipid mediators, specifically 20-hydroxyeicosatetraenoic acid (20-HETE), which is known to influence blood vessel function and inflammation. By studying these cellular mechanisms, the research seeks to uncover potential therapeutic targets that could improve health outcomes for individuals affected by obesity-related conditions.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that mitigate the cardiovascular and metabolic complications associated with obesity.

How similar studies have gone: Previous research has shown promising results in understanding the role of GPR75 and related pathways in metabolic and cardiovascular diseases, indicating that this approach has potential for success.

Where this research is happening

  • New York Medical College
    Valhalla, United States
    Active

Researchers

  • Principal investigator: Schwartzman, Michal Laniado — New York Medical College
  • Study coordinator: Schwartzman, Michal Laniado

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.